Search Orphan Drug Designations and Approvals
-
| Generic Name: | 64-fluoro-36-methox-27-methyl-5-thia-4,8-diaza-2(4,6)-tieno[3,2-d]pyrimidine-3(3,5)-pyridina-1(2,5)-thiophena-6(1,3)-benzeneacyclononaphan-7-one 5,5-dioxide |
|---|---|
| Date Designated: | 11/08/2022 |
| Orphan Designation: | Treatment of Neuroblastoma |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
AUM Biosciences 7265 Wisconsin Avenue Cullen Building Bethesda, Maryland 20814 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







